Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8851612rdf:typepubmed:Citationlld:pubmed
pubmed-article:8851612lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:8851612lifeskim:mentionsumls-concept:C0040341lld:lifeskim
pubmed-article:8851612lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8851612lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8851612lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:8851612lifeskim:mentionsumls-concept:C1272706lld:lifeskim
pubmed-article:8851612lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:8851612pubmed:issue3lld:pubmed
pubmed-article:8851612pubmed:dateCreated1997-1-7lld:pubmed
pubmed-article:8851612pubmed:abstractTextThe kinetics of the postantibiotic effect (PAE) during one dosing interval of tobramycin against Staphylococcus aureus and Pseudomonas aeruginosa was investigated. We determined the PAE at different time points during this dosing interval of 12 h in an in vitro pharmacokinetic model simulating human pharmacokinetics in which the half-life of tobramycin was adjusted to 2.4 +/- 0.2 h. Using an enzymatic method to inactivate tobramycin, we determined PAEs in samples extracted from the model at 1, 5, 8, and 12 h, corresponding with tobramycin concentrations of 20, 5, 2, and 1 times the MIC for the test organism. The PAE decreased significantly from 2.5 h at 1 h to 0 h at 12 h. No change in MIC was observed for the strains during the experiments. We conclude that the PAE decreases with decreasing tobramycin concentrations during a 12-h dosing interval and completely disappears after the concentration has reached the MIC for the test organism. On the basis of these observations, the emphasis that is placed on the PAE in discussions about the optimal dosing interval in aminoglycoside therapy is questionable.lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:languageenglld:pubmed
pubmed-article:8851612pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:citationSubsetIMlld:pubmed
pubmed-article:8851612pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8851612pubmed:statusMEDLINElld:pubmed
pubmed-article:8851612pubmed:monthMarlld:pubmed
pubmed-article:8851612pubmed:issn0066-4804lld:pubmed
pubmed-article:8851612pubmed:authorpubmed-author:VerbrughH AHAlld:pubmed
pubmed-article:8851612pubmed:authorpubmed-author:MoutonJ WJWlld:pubmed
pubmed-article:8851612pubmed:authorpubmed-author:den...lld:pubmed
pubmed-article:8851612pubmed:authorpubmed-author:VleggaarF PFPlld:pubmed
pubmed-article:8851612pubmed:authorpubmed-author:van GoorM PMPlld:pubmed
pubmed-article:8851612pubmed:issnTypePrintlld:pubmed
pubmed-article:8851612pubmed:volume40lld:pubmed
pubmed-article:8851612pubmed:ownerNLMlld:pubmed
pubmed-article:8851612pubmed:authorsCompleteYlld:pubmed
pubmed-article:8851612pubmed:pagination784-6lld:pubmed
pubmed-article:8851612pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:8851612pubmed:meshHeadingpubmed-meshheading:8851612-...lld:pubmed
pubmed-article:8851612pubmed:meshHeadingpubmed-meshheading:8851612-...lld:pubmed
pubmed-article:8851612pubmed:meshHeadingpubmed-meshheading:8851612-...lld:pubmed
pubmed-article:8851612pubmed:meshHeadingpubmed-meshheading:8851612-...lld:pubmed
pubmed-article:8851612pubmed:meshHeadingpubmed-meshheading:8851612-...lld:pubmed
pubmed-article:8851612pubmed:meshHeadingpubmed-meshheading:8851612-...lld:pubmed
pubmed-article:8851612pubmed:meshHeadingpubmed-meshheading:8851612-...lld:pubmed
pubmed-article:8851612pubmed:year1996lld:pubmed
pubmed-article:8851612pubmed:articleTitleAlteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model.lld:pubmed
pubmed-article:8851612pubmed:affiliationDepartment of Clinical Microbiology and Antimicrobial Therapy, Erasmus University Rotterdam, Netherlands.lld:pubmed
pubmed-article:8851612pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851612lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8851612lld:pubmed